Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
Go back to Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib| (NASDAQ: APLM) | Delayed: 23.21 -0.65 (2.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.86 | 52 Week High | $ | |||
| Open | $24.03 | 52 Week Low | $ | |||
| Day High | $24.03 | P/E | N/A | |||
| Day Low | $21.21 | EPS | $ | |||
| Volume | 5,852 | |||||
